Stocks Comparison
Cannabis Bioscience International vs Inotiv: revenue, profit, margins and growth compared
Cannabis Bioscience International brought in $303K of revenue in fiscal 2025, Inotiv $513M in fiscal 2025. Revenue changed by +21.8% at Cannabis Bioscience International and +4.5% at Inotiv on the year before, so Cannabis Bioscience International grew faster. Cannabis Bioscience International kept -181.1% of its revenue as net profit, Inotiv -13.4%.
Side by side, latest fiscal year
| CBIH | NOTVQ | |
|---|---|---|
| Fiscal year ended | FY2025 (May 31, 2025) | FY2025 (September 30, 2025) |
| Revenue | $303K | $513M |
| Revenue growth | +21.8% | +4.5% |
| Net income | -$548.8K | -$68.6M |
| Net margin | -181.1% | -13.4% |
| Free cash flow | n/a | -$27.1M |
| Free cash flow margin | n/a | -5.3% |
| Earnings per share (diluted) | -$0.00 | -$2.11 |
| Cash | $13K | $21.7M |
| Debt | $286.2K | $402.1M |
| Price to earnings | n/a | n/a |
| Market value | $1.2M | $383.8K |
| Dividend yield | n/a | n/a |
| Rank by revenue in sector | #567 of 587 · Industrials | #333 of 587 · Industrials |
Over the years
Questions about Cannabis Bioscience International and Inotiv
Which is bigger by revenue, Cannabis Bioscience International or Inotiv?
Inotiv is bigger by revenue: $513M in fiscal 2025, against $303K for Cannabis Bioscience International in fiscal 2025.
Which keeps more of its revenue as profit, Cannabis Bioscience International or Inotiv?
Cannabis Bioscience International had a net margin of -181.1% in fiscal 2025; Inotiv had -13.4% in fiscal 2025.
Which grew revenue faster, Cannabis Bioscience International or Inotiv?
In their latest fiscal years revenue changed by +21.8% at Cannabis Bioscience International and +4.5% at Inotiv.
Where do these numbers come from?
From the annual reports each company files with the SEC (10-K, or 20-F and 40-F for foreign companies), read from their XBRL data. Margins and growth are simple arithmetic on those figures. Nothing here is a recommendation.